Titan Biotech Limited (BOM:524717)

Market Cap	18.60B +387.9%
Revenue (ttm)	1.93B +19.4%
Net Income	272.03M +21.0%
EPS	6.58 +21.0%
Shares Out	41.32M
PE Ratio	68.36
Forward PE	n/a
Dividend	0.40 (0.09%)
Ex-Dividend Date	Sep 19, 2025

Volume	15,570
Average Volume	40,009
Open	450.05
Previous Close	428.65
Day's Range	438.00 - 450.05
52-Week Range	74.73 - 555.65
Beta	-0.48
RSI	51.02
Earnings Date	May 30, 2026

About Titan Biotech

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; a...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1992
• Employees: 467
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524717

Financial Performance

In fiscal year 2025, Titan Biotech's revenue was 1.56 billion, a decrease of -4.65% compared to the previous year's 1.64 billion. Earnings were 215.32 million, a decrease of -13.36%.